Scope of the
Report
The report titled “US Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an insight into the overall thyroid cancer market of the United States of America. The report analyzes in detail the segments of Thyroid Cancer Market that includes Thyroid Cancer Diagnostics Surgeries, Thyroid Histopathology Market, Thyroid Cancer Secondary Surgery and Thyroid Cancer Hormone Replacement Market. The report assesses thyroid cancer types, stages and incidence rate of the disease and also discusses the factors that will result in the demand and growth of the market. Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott Laboratories and Oxigene Inc. are profiled in the report.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/185273
.
Product Coverage
Thyroid Cancer Diagnostic Surgeries
Thyroid Cancer Histopathology Market
Thyroid Cancer Secondary Surgery
Thyroid Cancer Hormone Replacement
FNA biopsies
Thyroid Cancer Diagnostic Surgeries
Thyroid Cancer Histopathology Market
Thyroid Cancer Secondary Surgery
Thyroid Cancer Hormone Replacement
FNA biopsies
Company Coverage
Veracyte Inc.
Mylan Inc.
Forest Laboratories
Abott Laboratories
Oxigene Inc.
Veracyte Inc.
Mylan Inc.
Forest Laboratories
Abott Laboratories
Oxigene Inc.
Purchase a copy of US Thyroid Cancer Market
visit @ http://www.orbisresearch.com/contact/purchase/185273
For more information contact sales@orbisresearch.com .
Executive Summary
Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases.
Thyroid cancer, a type of malignant cancer, initiate from follicular and par follicular thyroid cells. The most effective treatment of thyroid cancer is surgical removal of thyroid gland followed by radioactive ablation and thyroid stimulating hormone (TSH) suppression therapy. Chemotherapy is also used in cases of metastasis and progressive stage of thyroid cancer. Thyroid cancer market is accelerating in the United States since 2010 and it is a disease which is fast on the rise. Incidence has more than doubled since the early 1970s, and for women, it is the cancer with the fastest-growing number of new cases.
On the back of high
incidence of thyroid cancer, it is anticipated that the thyroid cancer market
in US will observe impressive double digit growth in next five years. The
thyroid cancer diagnosis market is segmented into diagnostic surgeries,
histopathology, secondary surgery and annual new patient hormone replacement
therapy. The diagnostic technology has improved since 2011 and with use of
Afirma GEC test and Afirma FNA; the detection of even minor nodules has become
possible.
The report titled “US
Thyroid Cancer Market: Trends and Opportunities (2015-2019)” provides an
insight into overall thyroid cancer sector of United States of America. The
report includes detailed information on market size, installed base and
geographical segmentation of overall sector. The market segmentation on basis
of thyroid cancer type, stage and incidence rate is also given in detail. It
also discusses key growth drivers, challenges and trends of the market.
Further, companies like Veracyte Inc., Mylan Inc., Forest Laboratories, Abott
Laboratories and Oxigene Inc. are profiled in the report.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/us-thyroid-cancer-market-trends-and-opportunities-2015-2019
.
Some points from TOC:
1. Executive Summary
2. United States Thyroid Cancer
Market: An Introduction
2.1 Cancer Cells
2.2 Types of Thyroid Cancer
2.3 Diagnosis
2.4 Staging
2.5 Treatment
2.5.1 Surgery
2.5.2 Radioactive Iodine Therapy
2.5.3 External Radiation Therapy
2.6 Thyroid Cancer Drugs
2.1 Cancer Cells
2.2 Types of Thyroid Cancer
2.3 Diagnosis
2.4 Staging
2.5 Treatment
2.5.1 Surgery
2.5.2 Radioactive Iodine Therapy
2.5.3 External Radiation Therapy
2.6 Thyroid Cancer Drugs
3. US Thyroid Cancer Market: Sizing
and Growth
3.1 U.S Thyroid Cancer Market: 2010-2014
3.2 U.S Thyroid Cancer Market: 2015-2019
3.1 U.S Thyroid Cancer Market: 2010-2014
3.2 U.S Thyroid Cancer Market: 2015-2019
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment